Clarus Therapeutics is based in Northbrook. It has raised $47M in total funding. Latest round: Series C.
Clarus Therapeutics is based in Northbrook. Clarus Therapeutics has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2014. The round record for Clarus Therapeutics runs through 2014; nothing later has been disclosed. Investors on record include C-Bridge Capital, BioVeda Capital, Pavilion Capital, H.I.G. Ventures, Thomas, McNerney & Partners. 5 distinct backers are named across the disclosed rounds.
We update the Clarus Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Northbrook and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026